The Next Frontier: The Oral Small Molecule GLP-1s While injectable peptides like semaglutide and tirzepatide have revolutionized treatment, they are not the endgame
"BPC 157 and NO system." Current Pharmaceutical Design
Both studies were published June 22, 2025, in the New England Journal of Medicine , to coincide with presentations at the American Diabetes Associations 85 th Scientific Sessions
However, trials specifically examining the effect of antihyperglycemic treatment on CV events in older populations are lacking
This approach allows time to monitor the bodys response and metabolic adaptations while ensuring the reconstituted solution remains within its stability window
Note: It's important to rotate injection sites, as repeated injections into the same location can cause scarring and hardening of the fatty tissue, making future injections more difficult and interfering with absorption of the medication